製品: SENP1 Antibody
カタログ: AF0275
タンパク質の説明: Rabbit polyclonal antibody to SENP1
アプリケーション: WB IHC IF/ICC
Cited expt.: WB
反応性: Human, Mouse, Rat
予測: Pig, Bovine, Horse, Sheep, Rabbit, Dog
分子量: 80kDa; 73kD(Calculated).
ユニプロット: Q9P0U3
RRID: AB_2833445

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:500-1:3000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
予測:
Pig(100%), Bovine(100%), Horse(92%), Sheep(100%), Rabbit(91%), Dog(100%)
クローナリティ:
Polyclonal
特異性:
SENP1 Antibody detects endogenous levels of total SENP1.
RRID:
AB_2833445
引用形式: Affinity Biosciences Cat# AF0275, RRID:AB_2833445.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

SENP 1; SENP1; SENP1_HUMAN; Sentrin specific protease 1; Sentrin-specific protease 1; Sentrin/SUMO specific protease 1; Sentrin/SUMO specific protease; Sentrin/SUMO specific protease SENP 1; Sentrin/SUMO specific protease SENP1; Sentrin/SUMO-specific protease SENP1; SUMO1/sentrin specific peptidase 1; SUMO1/sentrin specific protease 1; SuPr 2; SuPr2;

免疫原

免疫原:

A synthesized peptide derived from human SENP1, corresponding to a region within N-terminal amino acids.

Uniprot:
遺伝子(ID):
発現特異性:
Q9P0U3 SENP1_HUMAN:

Highly expressed in testis. Expressed at lower levels in thymus, pancreas, spleen, liver, ovary and small intestine.

タンパク質の説明:
SENP1 Protease that catalyzes two essential functions in the SUMO pathway: processing of full-length SUMO1, SUMO2 and SUMO3 to their mature forms and deconjugation of SUMO1, SUMO2 and SUMO3 from targeted proteins. Deconjugates SUMO1 from HIPK2. Deconjugates SUMO1 from HDAC1, which decreases its transcriptional repression activity.
タンパク質配列:
MDDIADRMRMDAGEVTLVNHNSVFKTHLLPQTGFPEDQLSLSDQQILSSRQGHLDRSFTCSTRSAAYNPSYYSDNPSSDSFLGSGDLRTFGQSANGQWRNSTPSSSSSLQKSRNSRSLYLETRKTSSGLSNSFAGKSNHHCHVSAYEKSFPIKPVPSPSWSGSCRRSLLSPKKTQRRHVSTAEETVQEEEREIYRQLLQMVTGKQFTIAKPTTHFPLHLSRCLSSSKNTLKDSLFKNGNSCASQIIGSDTSSSGSASILTNQEQLSHSVYSLSSYTPDVAFGSKDSGTLHHPHHHHSVPHQPDNLAASNTQSEGSDSVILLKVKDSQTPTPSSTFFQAELWIKELTSVYDSRARERLRQIEEQKALALQLQNQRLQEREHSVHDSVELHLRVPLEKEIPVTVVQETQKKGHKLTDSEDEFPEITEEMEKEIKNVFRNGNQDEVLSEAFRLTITRKDIQTLNHLNWLNDEIINFYMNMLMERSKEKGLPSVHAFNTFFFTKLKTAGYQAVKRWTKKVDVFSVDILLVPIHLGVHWCLAVVDFRKKNITYYDSMGGINNEACRILLQYLKQESIDKKRKEFDTNGWQLFSKKSQEIPQQMNGSDCGMFACKYADCITKDRPINFTQQHMPYFRKRMVWEILHRKLL

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Pig
100
Bovine
100
Sheep
100
Dog
100
Horse
92
Rabbit
91
Xenopus
0
Zebrafish
0
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

研究背景

機能:

Protease that catalyzes two essential functions in the SUMO pathway. The first is the hydrolysis of an alpha-linked peptide bond at the C-terminal end of the small ubiquitin-like modifier (SUMO) propeptides, SUMO1, SUMO2 and SUMO3 leading to the mature form of the proteins. The second is the deconjugation of SUMO1, SUMO2 and SUMO3 from targeted proteins, by cleaving an epsilon-linked peptide bond between the C-terminal glycine of the mature SUMO and the lysine epsilon-amino group of the target protein. Deconjugates SUMO1 from HIPK2. Deconjugates SUMO1 from HDAC1 and BHLHE40/DEC1, which decreases its transcriptional repression activity. Deconjugates SUMO1 from CLOCK, which decreases its transcriptional activation activity. Deconjugates SUMO2 from MTA1. Deconjugates SUMO1 from METTL3. Desumoylates CCAR2 which decreases its interaction with SIRT1. Deconjugates SUMO1 from GPS2.

細胞の位置付け:

Nucleus. Cytoplasm.
Note: Shuttles between cytoplasm and nucleus.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
組織特異性:

Highly expressed in testis. Expressed at lower levels in thymus, pancreas, spleen, liver, ovary and small intestine.

タンパク質ファミリー:

Belongs to the peptidase C48 family.

参考文献

1). SUMOylation of TP53INP1 is involved in miR-30a-5p-regulated heart senescence. Experimental & molecular medicine, 2024 (PubMed: 39511427) [IF=9.5]

Application: WB    Species: Mouse    Sample: heart tissues

Fig. 7: Deficiency of miR-30a-5p promotes the interaction of TP53INP1 with p53 and TP53INP1 SUMOylation. a Representative immunoprecipitation detection of the interaction between p53 and TP53INP1 in the heart tissues of WT and KO mice. b Representative immunofluorescence images of p53 (green) and TP53INP1 (red) in NRCMs transfected with the control or miR-30a-5p inhibitor (scale bars = 50 μm). DAPI (blue) was used to counterstain the nucleus. c Heatmap of SUMOylation-related genes from RNA-seq data of NRCMs transfected with control or miR-30a-5p mimics. d qRT‒PCR analysis of SUMOylation-related genes in NRCMs transfected with control or miR-30a-5p mimics (n = 6 in each group). e qRT‒PCR analysis of SUMOylation-related genes in heart samples from WT and KO mice (n = 5 in each group). Representative western blotting images (f) and quantitative analysis (g) of SENP1 in NRCMs transfected with control or miR-30a-5p inhibitor (n = 3 in each group). h Representative immunoprecipitation blot showing the interaction of TP53INP1 with SUMO1 and p53 in the hearts of WT and KO mice. The data are presented as the means ± standard errors. Statistical significance was assessed using one-way ANOVA. WT wild-type, KO knockout, NC negative control, NRCMs neonatal rat cardiomyocytes, qRT‒PCR quantitative real‒time polymerase chain reaction.

2). SENP1 facilitates OM-MSC differentiation through activating OPTN-mediated mitophagy to mitigate the neurologic impairment following ICH. iScience, 2024 (PubMed: 38770132) [IF=5.8]

Application: WB    Species: Rat    Sample:

Figure 1 Dynamic levels of SENP1 during OM-MSC differentiation (A and B) qPCR and western blot were utilized to measure SENP1 level in OM-MSCs, astrocytes, and neurons. Data are represented as means ± SD. Statistical difference was determined using one-way analysis of variance test followed by Tukey multiple-comparison post hoc analysis. n = 3. ∗p < 0.05, ∗∗p < 0.01.

3). SENP1 attenuates hypoxia‑reoxygenation injury in liver sinusoid endothelial cells by relying on the HIF‑1α signaling pathway. Molecular medicine reports, 2024 (PubMed: 38426545) [IF=3.4]

Application: WB    Species: Mouse    Sample:

Figure 1. Expression of SENP1 in liver sinusoidal endothelial cells following H-R. (A and B) Western blotting analysis. (C) Reverse transcription-quantitative polymerase chain reaction analysis. Data were presented as the mean ± SD (n=3); ***P

4). Hypoxia maintains the fenestration of liver sinusoidal endothelial cells and promotes their proliferation through the SENP1/HIF-1α/VEGF signaling axis. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021 (PubMed: 33445109) [IF=2.5]

Application: WB    Species: mouse    Sample: Liver sinusoidal endothelial cells (LSECs)

Fig. 2. After hypoxic culture of mouse LSECs, the expressions of SENP1,HIF-1a,and VEGF are all up-regulated.(A)(B)(C)real-time PCR showing SENP1 or HIF-1a or VEGF mRNA after a certain period of hypoxia culture.The date are presented as mean ± SEM.**p < 0.01,***p < 0.001,****p < 0.0001,n ¼ 3per group.(D)Western results showing the expression level of SENP1 and HIF-1a after a certain time of hypoxia culture.(E)(F) ratio of SENP1 or HIF-1a vs b-actin in western results.The date are presented as mean ± SEM.*p < 0.05,**p < 0.01,***p < 0.001,n ¼ 3 per group.(G) ELISA assay of VEGF production in LSECs after a certain time of hypoxia culture.The date are presented as mean ± SEM.****p < 0.0001,n ¼ 3 per group.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.